Samsung Biologics Achieves Remarkable Growth in Q1 2025 Financial Results Samsung Biologics reports impressive financial results for Q1 2025, driven by operational efficiency and new partnerships, ensuring long-term growth.

Samsung Biologics Achieves Remarkable Growth in Q1 2025 Financial Results #South_Korea #Biopharmaceutical #Samsung_Biologics #Incheon #ADC_facility